Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Lipidomics of oxylipins in biological systems.
Patrignani P, Schebb NH, Werz O, Steinhilber D. Patrignani P, et al. Among authors: schebb nh. Front Pharmacol. 2023 Dec 6;14:1342596. doi: 10.3389/fphar.2023.1342596. eCollection 2023. Front Pharmacol. 2023. PMID: 38125891 Free PMC article. No abstract available.
Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples.
O'Donnell VB, Schebb NH, Milne GL, Murphy MP, Thomas CP, Steinhilber D, Gelhaus SL, Kühn H, Gelb MH, Jakobsson PJ, Blair IA, Murphy RC, Freeman BA, Brash AR, FitzGerald GA. O'Donnell VB, et al. Among authors: schebb nh. Nat Commun. 2023 Nov 9;14(1):7172. doi: 10.1038/s41467-023-41766-w. Nat Commun. 2023. PMID: 37945602 Free PMC article. No abstract available.
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber CG, Rabehl M, Pietzner A, Rohwer N, Rothe M, Pech M, Sangro B, Sharma R, Verslype C, Basu B, Sengel C, Ricke J, Schebb NH, Weylandt KH, Benckert J. Leineweber CG, et al. Among authors: schebb nh. Front Pharmacol. 2024 Jan 11;14:1354581. doi: 10.3389/fphar.2023.1354581. eCollection 2023. Front Pharmacol. 2024. PMID: 38273836 Free PMC article.
Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins.
Wang C, Kaufmann A, Kampschulte N, Elbelt U, Kassner U, Steinhagen-Thiessen E, Pietzner A, Schmöcker C, Datta D, Sanpietro T, Schebb NH, Weylandt KH, Rohwer N. Wang C, et al. Among authors: schebb nh. Atheroscler Plus. 2024 Feb 12;55:55-62. doi: 10.1016/j.athplu.2024.01.005. eCollection 2024 Mar. Atheroscler Plus. 2024. PMID: 38390468 Free PMC article.
134 results